Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S): Impact of predicted risk on the benefit of cholesterol-lowering treatment

European Heart Journal

Volumn 22, Issue 13, 2001, Pages 1119-1127

  Wilhelmsen, Lars ^a   Pyorala K ^b   Wedel, H ^c   Cook, T ^d   Pedersen, T ^e   Kjekshus, J ^f  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^d MERCK RESEARCH LABORATORIES   (United States)

^e AKER UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Diabetes; Hypertension; Lipids; Myocardial infarction; Prognosis; Smoking

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SCANDINAVIA; SMOKING; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SIMVASTATIN; SMOKING; TIME FACTORS;

EID: 0034918812     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2481     Document Type: Article

References (28)

1. Clinical guideline: Part II. Risk stratification after myocardial infarction
2. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction
3. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
4. Long-term prognosis after myocardial infarction in men with diabetes
5. Risk factors for long-term coronary prognosis after initial myocardial infarction: The Framingham Study
6. Ten-year survival after acute myocardial infarction: Comparison of patients with and without diabetes
7. Effects of cessation of smoking after myocardial infarction
8. Five-year prognosis after acute myocardial infarction in relation to a history of hypertension
9. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension
10. Prognostic importance of cholesterol levels after myocardial infarction
11. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
12. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
13. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
14. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
15. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
16. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
17. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: Subgroup analyses in the Scandinavian Simvastatin Survival Study
18. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study
19. Primary and subsequent coronary risk appraisal: New results from the Framingham Study
20. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
21. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years
22. Follow-up of 2,733 Japanese patients with myocardial infarction
23. Influence of a myocardial infarction on blood pressure and serum cholesterol
24. Influence of heart rate on mortality after acute myocardial infarction
25. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study
26. Changes in estimated coronary risk in the 1980s: Data from 38 populations in the WHO MONICA Project
27. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: A 16 year follow-up of the Primary Prevention Study, Göteborg, Sweden